Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Current ratio
Progyny, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.9×, down 0.8× from fiscal 2025 (2.7×). Over the past ten years it has ranged from 0.8× (fiscal 2018) to 3.7× (fiscal 2019); the current reading is higher than 67% of that period. That is above the Healthcare Plans industry median of 1.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.7× | (2.75%) |
| FY2024 | 2.8× | (18.60%) |
| FY2023 | 3.4× | 26.64% |
| FY2022 | 2.7× | 3.95% |
| FY2021 | 2.6× | 6.98% |
| FY2020 | 2.4× | (33.23%) |
| FY2019 | 3.7× | 350.81% |
| FY2018 | 0.8× | (13.91%) |
| FY2017 | 0.9× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.9× | (9.46%) |
| Jun 2026 | 2.1× | 0.44% |
| Mar 2026 | 2.1× | (21.96%) |
| Dec 2025 | 2.7× | (7.74%) |
| 28 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| PGNY Progyny, Inc. | 1.9× |
| ALHC Alignment Healthcare, Inc. compare | 1.7× |
| MOH Molina Healthcare, Inc compare | 1.7× |
| HUM Humana Inc. compare | 1.6× |
| CLOV Clover Health Investments, Corp. compare | 1.5× |
| ELV Elevance Health, Inc. compare | 1.5× |
| CNC Centene Corporation compare | 1.2× |
| CI Cigna Group compare | 0.7× |
| OSCR Oscar Health, Inc. compare | 0.0× |
| Healthcare Plans industry median | 1.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement